For instance the over-expression of Fatty Acid Synthase (FASN) which is a key lipogenic enzyme has been reported to be associated with proliferation, chemoresistance and poor prognosis of ovarian cancer and FASN inhibitors have been shown to promote cancer cell apoptosis [28]. Here, FASN is linked to ovarian carcinoma.